Your browser is no longer supported. Please, upgrade your browser.
Settings
PFE Pfizer Inc. daily Stock Chart
PFE [NYSE]
Pfizer Inc.
IndexDJIA S&P500 P/E24.35 EPS (ttm)1.72 Insider Own0.10% Shs Outstand5.62B Perf Week0.17%
Market Cap235.12B Forward P/E13.58 EPS next Y3.08 Insider Trans-13.42% Shs Float5.55B Perf Month-0.69%
Income10.35B PEG4.09 EPS next Q0.75 Inst Own76.70% Short Float2.49% Perf Quarter-0.29%
Sales53.65B P/S4.38 EPS this Y-11.90% Inst Trans-0.81% Short Ratio5.36 Perf Half Y-3.26%
Book/sh10.95 P/B3.82 EPS next Y6.10% ROA6.80% Target Price44.14 Perf Year15.38%
Cash/sh3.35 P/C12.48 EPS next 5Y5.96% ROE16.20% 52W Range34.32 - 46.47 Perf YTD-4.12%
Dividend1.44 P/FCF40.49 EPS past 5Y1.00% ROI10.20% 52W High-9.94% Beta0.73
Dividend %3.44% Quick Ratio1.30 Sales past 5Y0.80% Gross Margin79.30% 52W Low21.94% ATR0.69
Employees92400 Current Ratio1.60 Sales Q/Q2.00% Oper. Margin22.80% RSI (14)47.51 Volatility1.57% 1.68%
OptionableYes Debt/Eq0.66 EPS Q/Q-143.40% Profit Margin20.80% Rel Volume0.72 Prev Close42.35
ShortableYes LT Debt/Eq0.52 EarningsApr 30 BMO Payout72.00% Avg Volume25.80M Price41.85
Recom2.50 SMA20-1.02% SMA50-0.69% SMA2000.54% Volume18,614,890 Change-1.18%
Feb-20-19Resumed Citigroup Neutral $41
Jan-31-19Upgrade Credit Suisse Neutral → Outperform
Jan-31-19Upgrade Argus Hold → Buy
Jan-23-19Downgrade UBS Buy → Neutral
Dec-11-18Downgrade JP Morgan Overweight → Neutral
Nov-01-18Downgrade BMO Capital Markets Outperform → Market Perform
Jun-08-18Initiated Cantor Fitzgerald Overweight $45
Apr-05-18Downgrade Barclays Overweight → Equal Weight $41 → $38
Jan-29-18Reiterated SunTrust Hold $33 → $40
Sep-20-17Upgrade Morgan Stanley Equal-Weight → Overweight
Jul-20-17Downgrade Credit Suisse Outperform → Neutral
May-16-17Downgrade Citigroup Neutral → Sell
Dec-02-16Initiated Guggenheim Neutral
Nov-02-16Downgrade Argus Buy → Hold
Oct-13-16Downgrade Jefferies Buy → Hold
Jun-20-16Reiterated Jefferies Buy $42 → $40
May-12-16Initiated Berenberg Hold $38
May-04-16Reiterated UBS Buy $36 → $38
Apr-18-16Resumed Goldman Neutral $35
Apr-07-16Resumed Morgan Stanley Equal-Weight $35
Mar-22-19 01:24PM  Final Trades: Verizon, XPO, Pfizer, Alphabet and BB&T CNBC Videos
11:23AM  Aerie (AERI) Starts Phase II Study on Eye Candidate in Japan Zacks
08:02AM  Dow 30 Stock Roundup: AAPL Refreshes Product Lineup, BA Wins $327M Navy Order Zacks
Mar-21-19 01:00PM  Boeing's Lesson About The Dow ETF.com
10:10AM  Merck's Keytruda Picks Up Pace in Thriving Anti-PD-L1 Market Zacks
09:51AM  Pfizer buys stake in French gene company in deal worth up to $636M American City Business Journals
Mar-20-19 03:17PM  Invest in Americas Rising Healthcare Costs With These Stocks InvestorPlace
01:37PM  Pfizer buys stake in French gene therapy firm Vivet Reuters
11:30AM  Pfizer/Merck KGaA End Bavencio+Talzenna Ovarian Cancer Study Zacks
11:10AM  Conatus (CNAT) Focuses on Developing NASH Candidate Emricasan Zacks
10:43AM  Glaxo Presents Encouraging Data on Endometrial Cancer Drug Zacks
09:33AM  Pfizer Acquires Gene Therapy Portfolio in Deal that Could Total $636 Million TheStreet.com
07:54AM  Pfizer Adds to Big Pharma's Gene-Therapy Deal Streak The Wall Street Journal
07:46AM  The Daily Biotech Pulse: FDA Nod For Sage's Postpartum Depression Drug, Pfizer Invests In Gene Therapy Company Benzinga
07:20AM  Pfizer acquires option to buy Vivet Therapeutics for equivalent of $635.8 million MarketWatch
06:45AM  Pfizer Secures Exclusive Option to Acquire Gene Therapy Company Vivet Therapeutics Business Wire
06:00AM  5 High-Quality, High-Yielding Stocks Morningstar
04:16AM  Stocks - FedEx, Google Fall in Pre-market; General Mills Jumps Investing.com
Mar-19-19 07:15PM  Merck KGaA, Darmstadt, Germany, and Pfizer Announce Discontinuation of Phase III JAVELIN Ovarian PARP 100 Trial in Previously Untreated Advanced Ovarian Cancer PR Newswire
05:45PM  Pfizer (PFE) Gains As Market Dips: What You Should Know Zacks
12:28PM  Aerie (AERI) Starts Phase II Study on Eye Candidate AR-1105 Zacks
11:51AM  Allergan's Anti-Infective Gets FDA Nod for Pediatric Patients Zacks
10:31AM  3 Stocks to Build Your Portfolio Around Motley Fool
10:21AM  Why You Should Buy ABBV Stock for Income and Value InvestorPlace
10:00AM  Pfizer Invites Public to View and Listen to Webcast of April 30 Conference Call with Analysts Business Wire
Mar-18-19 06:44PM  Bristol-Myers & Pfizer Release Phase IV Data on Eliquis Zacks
01:36PM  Big Pharma Earnings Might Not Be as Good as They Look Barrons.com
11:17AM  UnitedHealth Shares Finding Their Mojo Again Investing.com
09:54AM  Group with consumer-friendly vibe pushes drugmakers' message Associated Press
09:01AM  The Zacks Analyst Blog Highlights: Pfizer, Roche, Merck, Allergan and J&J Zacks
Mar-17-19 11:45AM  AUGUSTUS Demonstrates Favorable Safety Results of Eliquis® Versus Vitamin K Antagonists in Non-Valvular Atrial Fibrillation Patients with Acute Coronary Syndrome and/or Undergoing Percutaneous Coronary Intervention Business Wire
Mar-15-19 10:58AM  Pisani: S&P rebalancing as some companies aggressively buy back stock CNBC Videos
10:31AM  Pharma Stock Roundup: Regulatory Updates From MRK, PFE, J&J, AGN & Others Zacks
10:09AM  Dow 30 Stock Roundup: PFE's Herceptin Biosimilar Gets FDA Nod, VZ to Launch 5G Soon Zacks
08:00AM  The Case Against Pfizer Stock and the Rest of the Industry InvestorPlace
Mar-14-19 04:12PM  Markets Right Now: Stocks end a wobbly day mostly lower Associated Press
01:36PM  What's the play on Wynn? Plus the trades on Citigroup & Pfizer in #AskHalftime CNBC Videos
05:01AM  Blue Chip Drug Stocks Face 'Reckoning' on Future Downgrades Investopedia
Mar-13-19 05:45PM  Pfizer (PFE) Gains But Lags Market: What You Should Know Zacks
02:27PM  Theravance (TBPH) Starts Dosing in Ulcerative Colitis Study Zacks
01:10PM  Lilly's Cyramza Successful in Phase III First-Line NSCLC Study Zacks
12:50PM  Aerie (AERI) Receives FDA Nod for Rocklatan to Treat Glaucoma Zacks
08:37AM  FDA medical adviser: 'Congress is owned by pharma' Yahoo Finance
Mar-12-19 04:28PM  BioNTech hires banks for IPO worth up to $800 million -sources Reuters
02:06PM  BioNtech hires banks for IPO worth up to $800 million - sources Reuters
01:29PM  Biontech stock offering could be worth as much as $800 million-sources Reuters
01:20PM  Option trading opportunities in Pfizer & Sirius XM CNBC Videos
10:50AM  Pfizer's Herceptin Biosimilar Trazimera Gets FDA Approval Zacks
10:01AM  Pfizer's (PFE) Kidney Cancer Drug Combo Gets EMA's Validation Zacks
Mar-11-19 07:37PM  U.S. FDA Approves Pfizers Oncology Biosimilar TRAZIMERA (trastuzumab-qyyp), a Biosimilar to Herceptin®1 Business Wire
07:25PM  Stocks Spike on M&A and Retail Sales Investopedia
04:56PM  FDA approves Pfizer's biosimilar to Roche's Herceptin Reuters
04:39PM  FDA approves Pfizer's biosimilar to Roche's Herceptin Reuters
10:57AM  Conatus' (CNAT) Q4 Earnings Top Estimates, Emricasan in Focus Zacks
10:06AM  The Zacks Analyst Blog Highlights: J&J, Lilly, Pfizer, AstraZeneca and Merck's Zacks
Mar-08-19 01:45PM  Pharma Stock Roundup: FDA OK's J&J Antidepressant, CHMP Recommends Several Drugs Zacks
01:00PM  Exchange Traded Funds: How To Find The Best ETFs Investor's Business Daily
Mar-07-19 02:47PM  5 Top Gene-Editing Stocks for 2019 Motley Fool
Mar-06-19 01:19PM  The Roche Merger Will Do Wonders for Spark Stock InvestorPlace
12:56PM  GlycoMimetics Inc (GLYC) Q4 2018 Earnings Conference Call Transcript Motley Fool
11:34AM  Lilly's Emgality Gets FDA Priority Review for Cluster Headache Zacks
11:25AM  Demographics are favorable for the healthcare sector Yahoo Finance Video
Mar-05-19 12:21PM  10 Hot Stocks to Buy Right Now InvestorPlace
10:05AM  AnTolRx Announces Pfizer Exercises Option To License Immune Tolerance Therapy For Potential Treatment Of Type 1 Diabetes PR Newswire
10:00AM  Pfizer Invites Public to View and Listen to Webcast of Pfizer Presentation at Healthcare Conference Business Wire
09:00AM  Lilly to Bring Half-Priced Version of Popular Humalog Insulin Zacks
07:24AM  The Daily Biotech Pulse: Novartis Psoriasis Drug Found Superior, Ascendis Offering, Adamas Earnings Benzinga
06:47AM  [$$] Scott Gottlieb to step down as head of FDA Financial Times
Mar-04-19 08:57PM  Pfizer Prices $5,000,000,000 Debt Offering Business Wire
04:24PM  This Biotech Stock Just Flew To A Record After Topping Pfizer In A Study Investor's Business Daily
12:31PM  Here's Why Ascendis Pharma Is Rocketing Higher Today Motley Fool
11:25AM  Pfizer Inc. -- Moody's assigns A1 rating to Pfizer's notes; stable outlook Moody's
10:05AM  AbbVie Gets CHMP Nod for Psoriasis Candidate Risankizumab Zacks
09:19AM  Can This Biotech Puppy Run With the Big Dogs? Motley Fool
08:20AM  Market Trends Toward New Normal in Pfizer, Hyatt Hotels, Wipro, Garmin, Ameren, and Qorvo Emerging Consolidated Expectations, Analyst Ratings GlobeNewswire
08:00AM  BioXcel Therapeutics Announces Addition of Merck KGaA, Darmstadt, Germany, and Pfizer to Clinical Collaboration with Nektar for Development of Triple-combination Therapy in Pancreatic Cancer GlobeNewswire
Mar-01-19 09:29AM  Pharma Stock Roundup: Roche to Buy ONCE, Lawmakers Grill CEOs Over High Drug Prices Zacks
09:26AM  Nektar (NKTR) Q4 Earnings Beat, NKTR-181 Review Extended Zacks
09:00AM  Nektar Therapeutics (NKTR) Q4 2018 Earnings Conference Call Transcript Motley Fool
08:35AM  Pfizer Receives Positive CHMP Opinion for LORVIQUA® (lorlatinib) for Certain Adult Patients with Previously-Treated ALK-Positive Advanced Non-Small Cell Lung Cancer Business Wire
Feb-28-19 10:01PM  Pfizer unit Meridian under civil investigation by U.S. Attorney Reuters
09:40PM  ICU Medical Inc (ICUI) Q4 2018 Earnings Conference Call Transcript Motley Fool
06:02PM  Top technician says charts point to healthy gains ahead for this stock CNBC Videos
03:53PM  5 Pharmaceutical Stocks With Big Moats and Bridges Kiplinger
12:31PM  Antares Pharma Inc (ATRS) Q4 2018 Earnings Conference Call Transcript Motley Fool
08:00AM  Pfizer Announces Serotypes Included in 20-Valent Pneumococcal Conjugate Vaccine Candidate Being Investigated for the Prevention of Invasive Disease and Pneumonia in Adults Aged 18 Years and Older Business Wire
Feb-27-19 03:49PM  Big Pharma's Showdown With Congress Over Drug Pricing: What It Really Means for You Motley Fool
11:20AM  The patent system keeps American drug prices so high Yahoo Finance Video
Feb-26-19 06:16PM  Lawmakers grill top pharma execs over high drug costs CNBC Videos
05:37PM  Senators grill pharmaceutical executives over rising drug prices Yahoo Finance Video
04:21PM  Fed Chair Jerome Powell slams ballooning healthcare spending Yahoo Finance Video
03:19PM  Congress Grills Drugmakers: 5 Key Takeaways Motley Fool
02:40PM  Corcept (CORT) Q4 Earnings Beat Estimates, Revenues In Line Zacks
01:42PM  The Latest: Senators urge pharma CEOs to rein in lobbyists Associated Press
12:07PM  Senators say will support Judiciary panel if it looks into drug patents Reuters
10:49AM  Senators grill pharma execs over prescription drug prices Yahoo Finance
10:34AM  Aerie (AERI) Q4 Earnings Miss, Rhopressa Gains Traction Zacks
Feb-25-19 07:50PM  [$$] Pharmaceutical Industry CEOs Face Senate Hearing on Drug Prices The Wall Street Journal
05:54PM  Technician says it's time to fade the biotech rally CNBC Videos
05:09PM  Pharma CEOs to face tough questions about skyrocketing drug prices Yahoo Finance
Pfizer Inc. discovers, develops, manufactures, and sells healthcare products worldwide. It offers medicines and vaccines in various therapeutic areas, including internal medicine, vaccines, oncology, inflammation and immunology, and rare diseases under the Lyrica, Chantix/Champix, Eliquis, Ibrance, Sutent, Xalkori, Inlyta, Xtandi, Enbrel, Xeljanz, Eucrisa, BeneFix, Genotropin, and Refacto AF/Xyntha brands. The company also provides consumer healthcare products that comprise over-the-counter medicines, including dietary supplement products under the Centrum, Caltrate, and Emergen-C names; pain management products under the Advil and ThermaCare names; gastrointestinal products under the Nexium 24HR/Nexium Control and Preparation H names; and respiratory and personal care products under the Robitussin, Advil Cold & Sinus, and ChapStick names. In addition, it offers products that would lose or have lost marketing patent protection; branded generic products; generic sterile injectable products; biosimilars; and anti-infectives under the Lipitor, Premarin family, Norvasc, Lyrica, Celebrex, Viagra, Inflectra/Remsima, Zyvox, Vfend, Revatio, Inspra, Medrol, Sulperazon, Fragmin, Tygacil, Nivestim, and Retacrit, Ixifi Infliximab BS names. Further, the company is also involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration and/or co-promotion agreements with Bristol-Myers Squibb Company, Astellas Pharma US, Inc., and Merck KGaA; licensing agreement with BionTech AG; collaboration agreements with Merck & Co., Inc. and Eli Lilly & Company. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
JOHNSON RADY AExecutive Vice PresidentMar 15Sale41.138,700357,83159,797Mar 18 06:37 PM
READ IAN CExecutive ChairmanMar 04Sale43.2950,7882,198,4741,639,280Mar 06 04:03 PM
READ IAN CExecutive ChairmanMar 04Sale43.17530,07822,882,7021,109,202Mar 06 04:03 PM
SUSMAN SALLYExecutive Vice PresidentMar 04Sale43.268,725377,444172,094Mar 06 03:29 PM
SUSMAN SALLYExecutive Vice PresidentMar 04Sale43.1463,9982,760,698108,096Mar 06 03:29 PM
Dolsten MikaelPresident R&DMar 04Sale43.5249,0822,136,293289,126Mar 05 04:54 PM
ROGERS DAWNExecutive Vice PresidentMar 04Sale42.9815,002644,79814,920Mar 05 04:55 PM
Dolsten MikaelPresident R&DMar 01Option Exercise31.34106,1913,328,057438,679Mar 05 04:54 PM
Dolsten MikaelPresident R&DMar 01Sale43.56100,4714,376,852338,208Mar 05 04:54 PM
ROGERS DAWNExecutive Vice PresidentFeb 27Option Exercise32.2319,297621,94245,049Mar 01 07:47 PM
SUSMAN SALLYExecutive Vice PresidentFeb 27Option Exercise32.2385,7632,764,141228,743Mar 01 07:47 PM
YOUNG JOHN DGroup PresidentFeb 27Option Exercise32.23154,3744,975,474441,923Mar 01 07:47 PM
GOETTLER MICHAELGroup PresidentFeb 27Option Exercise32.2330,017967,44848,652Mar 01 07:37 PM
Hwang AngelaGroup PresidentFeb 27Option Exercise32.2311,792380,05623,635Mar 01 07:37 PM
JOHNSON RADY AExecutive Vice PresidentFeb 27Option Exercise32.2330,017967,44881,341Mar 01 07:37 PM
LANKLER DOUGLAS MExecutive Vice PresidentFeb 27Option Exercise32.2364,3222,073,098123,145Mar 01 07:37 PM
Lewis-Hall Freda CExecutive Vice PresidentFeb 27Option Exercise32.2381,4752,625,939416,278Mar 01 07:37 PM
BOURLA ALBERTChief Executive OfficerFeb 27Option Exercise32.2364,3222,073,098331,982Mar 01 07:29 PM
CANGIALOSI LORETTA VSr. Vice President, ControllerFeb 27Option Exercise32.2325,729829,246121,743Mar 01 07:29 PM
DAMELIO FRANK AExecutive Vice PresidentFeb 27Option Exercise32.23182,2475,873,821588,177Mar 01 07:29 PM
YOUNG JOHN DGroup PresidentFeb 23Option Exercise21.0343,724919,516312,403Feb 26 07:45 PM
JOHNSON RADY AExecutive Vice PresidentFeb 23Option Exercise21.0318,004378,62461,182Feb 26 07:45 PM
BOURLA ALBERTChief Executive OfficerFeb 23Option Exercise21.0336,008757,248191,438Feb 26 07:45 PM
Lewis-Hall Freda CExecutive Vice PresidentFeb 23Option Exercise21.0387,4491,839,052388,024Feb 26 07:45 PM
DAMELIO FRANK AExecutive Vice PresidentFeb 23Option Exercise21.03185,1853,894,441522,576Feb 26 07:45 PM
SUSMAN SALLYExecutive Vice PresidentFeb 23Option Exercise21.0397,7372,055,409205,833Feb 26 07:46 PM
LANKLER DOUGLAS MExecutive Vice PresidentFeb 23Option Exercise21.0343,724919,51683,781Feb 26 07:45 PM
MACKENZIE ALEXANDER RExecutive Vice PresidentFeb 23Option Exercise21.0341,615875,163144,164Feb 26 07:10 PM
CANGIALOSI LORETTA VSr. Vice President, ControllerFeb 23Option Exercise21.0330,864649,070115,139Feb 26 07:10 PM
ROGERS DAWNExecutive Vice PresidentFeb 23Option Exercise21.0319,290405,66937,638Feb 26 07:10 PM
GOETTLER MICHAELGroup PresidentFeb 23Option Exercise21.0319,290405,66931,507Feb 26 07:11 PM
LANKLER DOUGLAS MExecutive Vice PresidentFeb 01Sale42.755,000213,75040,057Feb 01 07:21 PM
Dolsten MikaelPresident R&DJan 31Option Exercise29.78125,9683,751,425362,051Feb 01 07:28 PM
LANKLER DOUGLAS MExecutive Vice PresidentJan 30Sale41.1938,8001,598,07145,057Feb 01 07:21 PM
READ IAN CChairman & CEONov 02Option Exercise26.641,100,20129,312,5881,760,958Nov 06 03:46 PM
PFIZER INC10% OwnerOct 15Buy18.0055,5561,000,00822,032,040Oct 17 05:17 PM
Dolsten MikaelPresident R&DSep 13Option Exercise24.56181,7124,462,167234,299Sep 17 04:08 PM
OLSON LAURIE JExecutive Vice PresidentAug 13Sale41.0010,214418,77472,672Aug 14 05:04 PM
MACKENZIE ALEXANDER RExecutive Vice PresidentAug 03Sale39.5125,6421,013,171102,412Aug 06 03:19 PM
GOETTLER MICHAELGroup PresidentAug 01Sale39.7019,198762,11611,924Aug 03 03:38 PM
CANGIALOSI LORETTA VSr. Vice President, ControllerAug 01Sale40.1626,8141,076,93383,846Aug 03 03:36 PM
LUND-JURGENSEN KIRSTENExecutive Vice PresidentAug 01Sale40.0420,942838,5724,643Aug 03 03:35 PM
DAMELIO FRANK AExecutive Vice PresidentAug 01Sale40.00150,4846,019,360337,391Aug 03 03:33 PM
SUSMAN SALLYExecutive Vice PresidentJul 20Sale37.2240,3811,502,925115,096Jul 24 01:09 PM
READ IAN CChairman & CEOJul 16Sale37.36486,75318,186,315659,440Jul 17 04:59 PM
OLSON LAURIE JExecutive Vice PresidentJun 06Sale36.4519,000692,58282,886Jun 08 01:11 PM
CORNWELL W DONDirectorJun 04Sale36.405,223190,1170Jun 05 04:44 PM
READ IAN CChairman & CEOMay 01Sale36.01132,3124,764,0811,144,703May 03 04:19 PM